1. Home/
  2. Compounds/
  3. doxorubicin:navitoclax (2:1 mol/mol)

doxorubicin:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2doxorubicin:navitoclax (2:1 mol/mol)
PharmacoGx doxorubicin:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to doxorubicin:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA RRBP1 CTRPv2 pan-cancer AAC -0.11 0.001
mRNA C19orf48 CTRPv2 pan-cancer AAC 0.12 0.001
mRNA SLC35B1 CTRPv2 pan-cancer AAC -0.11 0.001
mRNA LEPROT CTRPv2 pan-cancer AAC -0.12 0.001
mRNA KIDINS220 CTRPv2 pan-cancer AAC 0.11 0.001
mRNA UTP4 CTRPv2 pan-cancer AAC -0.1 0.001
mRNA UPF3B CTRPv2 pan-cancer AAC 0.11 0.001
mRNA SNCB CTRPv2 pan-cancer AAC 0.1 0.001
mRNA SNAP23 CTRPv2 pan-cancer AAC -0.11 0.001
mRNA KIAA1683 CTRPv2 pan-cancer AAC 0.11 0.001
Download CSV